Literature DB >> 15760405

A comparison of surgical outcomes and quality of life surveys in right lobe vs. left lateral segment liver donors.

Abhinav Humar1, Eric Carolan, Hassan Ibrahim, Kirsten Horn, Elizabeth Larson, Brooke Glessing, Raja Kandaswamy, Rainer W Gruessner, John Lake, William D Payne.   

Abstract

Concern remains regarding the possibly higher risk to living liver donors of the right lobe (RL), as compared with the left lateral segment (LLS). We studied outcomes and responses to quality of life (QOL) surveys in the two groups. From 1997 to 2004, we performed 49 living donor liver transplants (LDLTs): 33 RL and 16 LLS. Notable differences included a higher proportion of female and unrelated donors in the RL group. A significantly larger liver mass was resected in RL (vs. LLS) donors: 720 (vs. 310) g, p = 0.01; RL donors also had greater blood loss (398 vs. 240 mL, p = 0.04) and operative times (7.2 vs. 5.7 h, p = 0.05). However, those findings did not translate into significant differences in donor morbidity. The complication rate was 12.5% in LLS donors and 9.1% in RL donors (p = ns). Per a QOL survey at 6 months postdonation, no significant differences were noted in SF-12 scores for the two groups. Recovery times were somewhat longer for RL donors. Mean time off work was 61.0 days for RL donors and 32.4 days for LLS donors (p = 0.004). RL donation is associated with greater operative stress for donors, but not necessarily with a more complicated recovery or differences in QOL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15760405     DOI: 10.1111/j.1600-6143.2005.00767.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

Review 1.  A review of life quality in living donors after liver transplantation.

Authors:  Dong-Wei Xu; Xi-Dai Long; Qiang Xia
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study.

Authors:  Mary Amanda Dew; Andrea F DiMartini; Daniela P Ladner; Mary Ann Simpson; Elizabeth A Pomfret; Brenda W Gillespie; Robert M Merion; Jarcy Zee; Abigail R Smith; Susan Holtzman; Averell H Sherker; Robert Weinrieb; Robert A Fisher; Jean C Emond; Chris E Freise; James R Burton; Zeeshan Butt
Journal:  Transplantation       Date:  2016-06       Impact factor: 4.939

Review 3.  Quality of life for donors after living donor liver transplantation: a review of the literature.

Authors:  Neehar D Parikh; Daniela Ladner; Michael Abecassis; Zeeshan Butt
Journal:  Liver Transpl       Date:  2010-12       Impact factor: 5.799

4.  Patterns and predictors of sexual function after liver donation: The Adult-to-Adult Living Donor Liver Transplantation Cohort study.

Authors:  Andrea F DiMartini; Mary Amanda Dew; Zeeshan Butt; Mary Ann Simpson; Daniela P Ladner; Abigail R Smith; Peg Hill-Callahan; Brenda W Gillespie
Journal:  Liver Transpl       Date:  2015-05       Impact factor: 5.799

5.  Health-related quality of life after anonymous nondirected living liver donation: A multicenter collaboration.

Authors:  Muhammad H Raza; Whitney E Jackson; Angela Dell; Li Ding; James Shapiro; Elizabeth A Pomfret; Yuri Genyk; Linda Sher; Juliet Emamaullee
Journal:  Am J Transplant       Date:  2020-09-03       Impact factor: 8.086

6.  Assessment of Fibrotic Liver Regeneration After Partial Hepatectomy With Intravoxel Incoherent Motion Diffusion-Weighted Imaging: An Experimental Study in a Rat Model With Carbon Tetrachloride Induced Liver Injury.

Authors:  Shuangshuang Xie; Caixin Qiu; Yajie Sun; Yongquan Yu; Zhandong Hu; Kun Zhang; Lihua Chen; Yue Cheng; Mingzhu Bao; Quansheng Zhang; Jinxia Zhu; Robert Grimm; Wen Shen
Journal:  Front Physiol       Date:  2022-02-18       Impact factor: 4.566

7.  Long-term quality of life after liver donation in the adult to adult living donor liver transplantation cohort study (A2ALL).

Authors:  Daniela P Ladner; Mary Amanda Dew; Sarah Forney; Brenda W Gillespie; Robert S Brown; Robert M Merion; Chris E Freise; Paul H Hayashi; Johnny C Hong; April Ashworth; Carl L Berg; James R Burton; Abraham Shaked; Zeeshan Butt
Journal:  J Hepatol       Date:  2014-09-06       Impact factor: 30.083

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.